OA10 is a novel p38alpha mitogen-activated protein kinase inhibitor that suppresses osteoclast differentiation and bone resorption.

about

Screening, diagnosis and treatment of osteoporosis: a brief review

P2860

Q26996726-2F521C4A-EE28-442F-A73A-4A0ABDC8B831

P2860

OA10 is a novel p38alpha mitogen-activated protein kinase inhibitor that suppresses osteoclast differentiation and bone resorption.

Item

http://www.wikidata.org/entity/Q50701558

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

OA10 is a novel p38alpha mitog ...... entiation and bone resorption.

@en

OA10 is a novel p38alpha mitog ...... entiation and bone resorption.

@nl

type

Item

label

OA10 is a novel p38alpha mitog ...... entiation and bone resorption.

@en

OA10 is a novel p38alpha mitog ...... entiation and bone resorption.

@nl

prefLabel

OA10 is a novel p38alpha mitog ...... entiation and bone resorption.

@en

OA10 is a novel p38alpha mitog ...... entiation and bone resorption.

@nl

P1476

OA10 is a novel p38alpha mitog ...... entiation and bone resorption.

@en

P2093

A Qin

http://www.w3.org/2001/XMLSchema#string

B Tian

http://www.w3.org/2001/XMLSchema#string

H W Li

http://www.w3.org/2001/XMLSchema#string

H Zheng Ming

http://www.w3.org/2001/XMLSchema#string

K R Dai

http://www.w3.org/2001/XMLSchema#string

Q Jiang

http://www.w3.org/2001/XMLSchema#string

T Jiang

http://www.w3.org/2001/XMLSchema#string

Y P Yu

http://www.w3.org/2001/XMLSchema#string

Z A Zhu

http://www.w3.org/2001/XMLSchema#string

Z J Zhai

http://www.w3.org/2001/XMLSchema#string

P2860

Systemically administered bone morphogenetic protein-6 restores bone in aged ovariectomized rats by increasing bone formation and suppressing bone resorption

The identification of novel p38α isoform selective kinase inhibitors having an unprecedented p38α binding mode

Bone resorption by osteoclasts

Matrix-embedded cells control osteoclast formation

Evidence for osteocyte regulation of bone homeostasis through RANKL expression

Pamapimod, a novel p38 mitogen-activated protein kinase inhibitor: preclinical analysis of efficacy and selectivity

Prevention of wear particle-induced osteolysis by a novel V-ATPase inhibitor saliphenylhalamide through inhibition of osteoclast bone resorption

Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts

c-Src links a RANK/αvβ3 integrin complex to the osteoclast cytoskeleton.

Ethyl acetate fraction from Cudrania tricuspidata inhibits IL-1beta-stimulated osteoclast differentiation through downregulation of MAPKs, c-Fos and NFATc1

P304

959-966

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCB.24744

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24357524

http://www.w3.org/2001/XMLSchema#string

OA10 is a novel p38alpha mitogen-activated protein kinase inhibitor that suppresses osteoclast differentiation and bone resorption.

about

P2860

P2860

OA10 is a novel p38alpha mitogen-activated protein kinase inhibitor that suppresses osteoclast differentiation and bone resorption.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698